CTOs on the Move

Lake Shore Inn Nursing Home

www.lsiwaseca.com

 
Lake Shore Inn Nursing Home is a Waseca, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Cybertech Medical

Cybertech Medical is a La Verne, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AFA Capital

AFA Capital is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MyLabsDirect

My Labs Direct is a certified and accredited diagnostic lab company that specializes in hassle-free blood testing through an innovative self-collection device that delivers precision accuracy on hundreds of health and wellness lab tests.

FOI Services

FOI Services is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.